Biologics: Targets and Therapy
Volume 4, 2010 - Issue
Open access
81
Views
0
CrossRef citations to date
0
Altmetric
Review
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
Jaclyn FlaniganYale Cancer Center/Yale University School of Medicine New Haven, CT, USA
, Hari DeshpandeYale Cancer Center/Yale University School of Medicine New Haven, CT, USA
& Scott GettingerYale Cancer Center/Yale University School of Medicine New Haven, CT, USACorrespondence[email protected]
Pages 237-243
|
Published online: 26 Aug 2010
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.